Will New Trial Solution Data Spark a Rally for this Dual-Listed Gen AI Clinical Trial Leader?
2024年3月1日 - 12:00AM
AllPennyStocks.com
Parkinson’s disease is a complex and debilitating disease with a
need for novel treatment options. This firm’s goal is to advance
its understanding of the biological markers and...
To read the full story on AllPennyStocks.com, click
here.
NetraMark (CSE:AIAI)
過去 株価チャート
から 4 2024 まで 5 2024
NetraMark (CSE:AIAI)
過去 株価チャート
から 5 2023 まで 5 2024
